Ledger.Open graph →
SEC Form D · filed February 28, 2024

Radiance Biopharma, Inc

Offering
$30.0M
Sold
$250K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (4)

Robert Brooks · KANSAS CITY, MOExec · DirectorMarc Lippman · Miami, FLExec · DirectorRobert Brooks · KANSAS CITY, MOExec · DirectorMarc Lippman · Plantation, FLExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗

Radiance Biopharma, Inc. — SEC Form D filing (2024) | Ledger